Liver cirrhosis as a result of chronic hepatitis C
https://doi.org/10.22625/2072-6732-2014-6-1-67-71
Abstract
The incidence of chronic hepatitis C in St. Petersburg is 124.4 per 100 000 population. The number of patients with liver cirrhosis is significant.
Aim of this study: to examine the demographic, clinical and epidemiological characteristics of patients with cirrhosis in the results of chronic hepatitis C.
Materials and methods: 100 patients with cirrhosis due to chronic hepatitis C in age 31–70 years were included. Patients with infection hepatitis viruses A and B, HIV, alcohol abuse, drug addicts, previously received antiviral therapy were excluded. Liver cirrhosis was diagnosed on the basis clinical, laboratory and instrumental investigations.
Results: most patients (86,2% male and 81,7% female) are socially adapted. In 23,2% of patients antibodies to hepatitis C virus were first detected simultaneously with the diagnosis of cirrhosis. Medical procedures were the most common route of infection (25,6% male and 57,1% female). Genotype 1 was dominant (65.7%). Viral load over 800 000 IU/ml was detected in 36,7% of patients. ALT activity was normal or not more than 2 upper limit of normal in 59% of patients, AST – 47%. Normal levels of total bilirubin were recorded in 37% of cases.
Conclusions: the first detection of antibodies to hepatitis C virus at the stage of cirrhosis, absence of jaundice, normal or low cytolytic activity once again confirms the need for screening for markers of hepatitis C virus. Dominance of genotype 1 is probably due on the one hand with features routes of transmission, and the other – with the speed of transformation chronic hepatitis to cirrhosis.
About the Authors
A. A. SukhorukRussian Federation
O. A. Gerasimova
Russian Federation
E. V. Esaulenko
Russian Federation
References
1. World Health Organization. Viral hepatitis: Report by the Secretariat. [Internet] [cited2014Feb17]. Available from: http://apps.who.int/gb/ebwha/pdf_files/EB126/B126_15-en.pdf
2. World Health Organization. Prevention and control of viral hepatitis infection: Framework for global action. [Internet] [cited2014Feb17]. Available from: http://www. who.int/csr/disease/hepatitis/ GHP_ framework.pdf
3. Shakhgildyan IV, Yasinskiy AA, Mikhaylov MI, et al. Jurnal infektologii. 2010; 2(4): 127-128.
4. Pokrovskiy VI, Zhebrun AB, editors. Viral hepatitis in the Russian Federation: Analytical review. Issue 8. St.Petersburg: Saint-Petersburg Pasteur Scientific and Research Institute of Epidemiology and Microbiology; с 2011. 116р.
5. Mukomolov SL, Levakova IA. Infektsiya i immunitet. 2011; 1(3): 255–262.
6. Feofanova AV. Immunogematologicheskaya otsenka metodov gemokomponentnoy terapii u onkologicheskikh bolnykh [Immunohaematological assessment methods gemokomponentnoy therapy in cancer patients] [master’s thesis]. Saint-Petersburg( Russia): SPbGMU; 2010. Russian.
7. Esaulenko YeV. V mire virusnykh gepatitov. 2013; 4: 14-9.
8. Zhdanov KV, Lobzin Yu V, Gusev DA, et al. Viral hepatitis. Saint-Petersburg (Russia): Foliant; с2011. 304р.
Review
For citations:
Sukhoruk A.A., Gerasimova O.A., Esaulenko E.V. Liver cirrhosis as a result of chronic hepatitis C. Journal Infectology. 2014;6(1):67-71. (In Russ.) https://doi.org/10.22625/2072-6732-2014-6-1-67-71